Share-based compensation | Note 10. Share-based compensation 2019 Share incentive plan In June 2019, the Company’s Board of Directors adopted, and its shareholders approved, the 2019 Share Incentive Plan (“2019 Plan”). The 2019 Plan provides for the grant of incentive share options, nonqualified share options, share appreciation rights, restricted share awards (“RSAs”), restricted share units (“RSUs”), other share-based awards and performance awards. The number of shares that were reserved for issuance under the 2019 Plan was 3,400,000, in addition to the 240,037 RSAs and RSUs the Company granted in substitution for unvested Class B Units or phantom units in Vector Cambium Holdings (Cayman), L.P. (“VCH L.P.”) in connection with the Company’s initial public offering (“IPO”) based on a price of $12.00 per share (“Recapitalization Awards”). The share reserve under the 2019 Plan is automatically increased on the first day of each fiscal year, beginning with the fiscal year ended December 31, 2020 and continuing until, and including, the fiscal year ending December 31, 2029. The number of shares added annually is equal to the lowest of 1,320,000 shares, 5% of the number of the Company’s shares outstanding on the first day of such fiscal year, or an amount determined by the Board of Directors. On March 1, 2021, the Company registered 1,301,726 additional shares that may be issued under the 2019 Plan. The Company’s employees, officers, directors, consultants, and advisors are eligible to receive awards under the 2019 Plan. Incentive share options, however, may only be granted to its employees. Participants in the 2019 Plan will also consist of persons to whom Recapitalization Awards were granted. The following table summarizes changes in the number of shares available for grant under the Company’s equity incentive plans during the six-month period ended June 30, 2021 (unaudited): Number of shares Available for grant at December 31, 2020 832,134 Added to 2019 Share Incentive Plan 1,301,726 RSUs granted (247,670 ) Options granted (116,035 ) Shares withheld in settlement of taxes and/or exercise price 43,889 Forfeitures 19,527 Available for grant at June 30, 2021 1,833,571 Share-based compensation The following table shows total share-based compensation expense for the three-month and six-month periods ended June 30, 2020 and 2021 (unaudited and in thousands): Three Months Ended June 30, Six Months Ended June 30, 2020 2021 2020 2021 Cost of revenues $ 18 $ 50 $ 35 $ 69 Research and development 422 842 790 1,359 Sales and marketing 243 539 475 834 General and administrative 257 667 451 1,246 Total share-based compensation expense $ 940 $ 2,098 $ 1,751 $ 3,508 For the three-month and six-month periods ended June 30, 2020, the Company recorded share-based compensation expense of $0.0 million and $0.0 million, respectively, and for the three-month and six-month periods ended June 30, 2021, the Company recorded share-based compensation expense of $0.2 million and $0.3 million, respectively, related to the Company’s employee share purchase plan. For the three-month period ended June 30, 2020 and 2021, the Company recorded corresponding income tax benefits of $0.2 million and $1.1 million, respectively, and for the six-month period ended June 30, 2020 and 2021, the Company recorded corresponding tax benefits of $0.3 million and $2.4 million, respectively. As of June 30 , 2021 , the Company estimates the pre-tax unrecognized compensation expense of $ million , net of estimated forfeitures, related to all unvested share-based awards, including s hare options, restricted share units and restricted share awards will be recognized through the first quarter of 202 5 . The Company expects to satisfy the exercise of s hare options and future distributions of shares for restricted share units and restricted share awards by issuing new ordinary shares that have been reserved under the 2019 Plan. The Company uses the Black-Scholes option pricing model to estimate the fair value of share options. The Company utilized a forfeiture rate of 5% during the six-month period ended June 30, 2021 for estimating the forfeitures of share options and restricted share units granted. Share options The following is a summary of option activity for the Company’s share incentive plans for the six-month period ended June 30, 2021 (unaudited): Options Weighted average exercise price Weighted Average remaining contractual term (years) Aggregate intrinsic value Outstanding at December 31, 2020 3,164,185 $ 11.24 8.8 $ 43,793,890 Options granted 116,035 $ 42.52 — $ — Options exercised (312,404 ) $ 10.71 — $ — Options forfeited (17,812 ) $ 10.81 — $ — Outstanding at June 30, 2021 2,950,004 $ 12.53 8.4 $ 105,672,118 Options exercisable at June 30, 2021 929,847 $ 10.58 8.1 $ 35,120,703 Options vested and expected to vest at June 30, 2021 2,894,174 $ 12.52 8.4 $ 103,689,431 Share options typically have a contractual term of ten years from grant date. At June 30, 2021, the aggregate intrinsic value of options exercisable under the Company’s share incentive plans was $35.1 million. The Company had 312,404 options exercised during the six-month period ended June 30, 2021. At June 30, 2021, there was $11.0 million in unrecognized pre-tax share-based compensation expense, net of estimated forfeitures, related to unvested share option awards. The unrecognized share-based compensation expense is expected to be recognized through the first quarter of 2025. The fair value of options granted are estimated on the date of grant using the Black-Scholes option pricing model. The fair value of share options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of share options is estimated using the following weighted-average assumptions (unaudited): Six Months Ended June 30, 2020 2021 Expected dividend yield — — Risk-free interest rate 0.43 % 1.14 % Weighted-average expected volatility 48.9 % 50.9 % Expected term (in years) 6.5 6.5 Weighted average grant-date fair value per share of options granted $ 3.22 $ 21.36 Restricted shares The following is a summary of restricted shares activity for the Company’s share incentive plans for the six-month period ended June 30, 2021 (unaudited): Units Weighted average grant date fair value RSU and RSA balance at December 31, 2020 519,197 $ 4.89 RSUs and RSAs granted 247,670 $ 42.63 RSUs and RSAs vested (160,391 ) $ 4.87 RSUs and RSAs forfeited (1,715 ) $ 42.52 RSU and RSA balance at June 30, 2021 604,761 $ 20.25 RSUs and RSAs expected to vest at June 30, 2021 604,761 $ 20.25 During the six-month period ended June 30, 2021, 247,670 RSUs were granted under the Company’s 2019 Share Incentive Plan and 160,391 RSUs vested. The Company withheld 43,889 of those shares to pay the employees’ portion of the minimum payroll withholding taxes. As of June 30, 2021, there was $10.6 million in unrecognized pre-tax compensation expense, net of estimated forfeitures, related to unvested share awards. The unrecognized compensation expense is expected to be recognized through the first quarter of 2025. Employee share purchase plan In June 2019, the Company’s Board of Directors adopted, and its shareholders approved, the Employee Share Purchase Plan (“ESPP”). The ESPP was effective on June 25, 2019, and the initial offering period of six months commenced on January 1, 2021 and ran through June 30, 2021. The purchase price of the shares is 85% of the lower of the fair market value of the Company’s ordinary shares on the first trading day of the offering period and the purchase date. Upon adoption of the plan, a total of 550,000 shares were made available under the ESPP. Per the ESPP, the number of shares that will be available for sale also includes an annual increase on the first day of each fiscal year beginning in 2020, equal to the lesser of: 275,000 shares, 1% of the outstanding shares as of the last day of the immediately preceding fiscal year, or such other amount as the administrator may determine. The Company registered 256,730 and 260,345 additional shares on March 24, 2020 and March 1, 2021, respectively, for a total of 1,067,075 shares that may be issued under the ESPP. For the three-month and six-month periods ended June 30, 2021, the Company recognized $0.2 million and $0.3 million, respectively, of share-based compensation expense related to the ESPP. There were 39,061 shares issued under the ESPP during the three and six-month periods ended June 30, 2021. |